The Texas Life Science Center for Innovation and Commercialization (Texas Life Science Center, TLSCIC, TLSC) was formed to provide a central resource for the evaluation and commercialization of early stage life science companies in Texas, through the Texas Emerging Technology Fund (ETF).  The ETF was originally established as a $200 million fund by the State of Texas to facilitate gap funding for technology ventures. Our advisory board consists of life science leaders from across the state, with backgrounds ranging from academia, technology transfer, industry, and venture capital.  Emerging life science companies in the State of Texas can take advantage of the TLSC’s resources and expertise as they move their products through the development process. 

 

All life science applications to the ETF for commercialization awards are reviewed by the TLSC and the local Regional Centers for Innovation and Commercialization (RCIC).  Companies may choose to submit their applications to either their local RCICs, who upon review will send the application to the TLSC, or directly to the TLSC.  The TLSC accepts applications on a quarterly basis.